BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21570666)

  • 1. Role of fibrin structure in thrombosis and vascular disease.
    Cilia La Corte AL; Philippou H; Ariëns RA
    Adv Protein Chem Struct Biol; 2011; 83():75-127. PubMed ID: 21570666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
    Gaule TG; Ajjan RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin Formation, Structure and Properties.
    Weisel JW; Litvinov RI
    Subcell Biochem; 2017; 82():405-456. PubMed ID: 28101869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen and fibrin.
    Weisel JW
    Adv Protein Chem; 2005; 70():247-99. PubMed ID: 15837518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms that regulate clot structure/function.
    Ariëns RA
    Thromb Res; 2016 May; 141 Suppl 2():S25-7. PubMed ID: 27207417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus gordonii FSS2 Challisin affects fibrin clot formation by digestion of the αC region and cleavage of the N -terminal region of the Bβ chains of fibrinogen.
    Harty DW; Farahani RM; Simonian MR; Hunter L; Hunter N
    Thromb Haemost; 2012 Aug; 108(2):236-46. PubMed ID: 22552295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
    Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis.
    Cone SJ; Fuquay AT; Litofsky JM; Dement TC; Carolan CA; Hudson NE
    Acta Biomater; 2020 Apr; 107():164-177. PubMed ID: 32105833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants in the
    Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
    Ząbczyk M; Ariëns RAS; Undas A
    Cardiovasc Res; 2023 Mar; 119(1):94-111. PubMed ID: 36662542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
    Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
    Front Immunol; 2019; 10():2967. PubMed ID: 31921206
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
    Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
    Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.